BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9586613)

  • 1. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia.
    Kurita Y; Masuda H; Terada H; Suzuki K; Fujita K
    Urology; 1998 Apr; 51(4):595-600. PubMed ID: 9586613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen and transition zone index - powerful predictors for acute urinary retention in men with benign prostatic hyperplasia.
    Milonas D; Trumbeckas D
    Medicina (Kaunas); 2003; 39(11):1071-7. PubMed ID: 14646460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia.
    Shinbo H; Kurita Y; Takada S; Imanishi T; Otsuka A; Furuse H; Nakanishi T; Mugiya S; Ozono S
    Urology; 2010 Dec; 76(6):1440-5. PubMed ID: 20646746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy.
    Crook J; Toi A; McLean M; Pond G
    Brachytherapy; 2002; 1(3):131-7. PubMed ID: 15090275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transrectal ultrasonography to predict the clinical outcome of transurethral microwave thermotherapy in patients with benign prostatic hyperplasia.
    Kurita Y; Ushiyama T; Suzuki K; Fujita K; Kawabe K
    Int J Urol; 1996 Nov; 3(6):448-53. PubMed ID: 9170571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonic measurement of bladder weight as a possible predictor of acute urinary retention in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Miyashita H; Kojima M; Miki T
    Ultrasound Med Biol; 2002 Aug; 28(8):985-90. PubMed ID: 12217433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant changes in volume of seminal vesicles as determined by transrectal sonography in relation to age and benign prostatic hyperplasia.
    Hayakawa T; Naya Y; Kojima M
    Tohoku J Exp Med; 1998 Nov; 186(3):193-204. PubMed ID: 10348215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistive index: a newly identified predictor of outcome of transurethral prostatectomy in patients with benign prostatic hyperplasia.
    Shinbo H; Kurita Y; Nakanishi T; Imanishi T; Otsuka A; Furuse H; Mugiya S; Ozono S
    Urology; 2010 Jan; 75(1):143-7. PubMed ID: 19854491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate.
    Kojima M; Naya Y; Inoue W; Ukimura O; Watanabe M; Saitoh M; Watanabe H
    J Urol; 1997 Jun; 157(6):2160-5. PubMed ID: 9146607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transrectal ultrasonic planimetry of the prostate in relation to age and lower urinary tract symptoms among elderly men in Japan.
    Taneike R; Kojima M; Saitoh M
    Tohoku J Exp Med; 1997 Oct; 183(2):135-50. PubMed ID: 9526804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transrectal ultrasound parameters: presumed circle area ratio and transitional zone area in the evaluation of patients with lower urinary tract symptoms.
    Desai MM
    J Endourol; 1999 May; 13(4):317-21. PubMed ID: 10405914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy.
    Tsuru N; Kurita Y; Masuda H; Suzuki K; Fujita K
    Int J Urol; 2002 Aug; 9(8):427-30. PubMed ID: 12225338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy.
    Thomas MD; Cormack R; Tempany CM; Kumar S; Manola J; Schneider L; Hurwitz MD; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):905-8. PubMed ID: 10863058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary bladder characteristics via ultrasound as predictors of acute urinary retention in men with benign prostatic hyperplasia.
    Ho CC; Ngoo KS; Hamzaini AH; Rizal AM; Zulkifli MZ
    Clin Ter; 2014; 165(2):75-81. PubMed ID: 24770808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia.
    Lepor H; Nieder A; Feser J; O'Connell C; Dixon C
    J Urol; 1997 Jul; 158(1):85-8. PubMed ID: 9186329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transition zone index in predicting therapeutic efficacy of benign prostatic hyperplasia].
    Otani T; Fujimoto K; Yoshida K; Ozono S; Hirao Y; Okajima E; Hayashi Y; Kurumatani N
    Nihon Hinyokika Gakkai Zasshi; 2002 Jan; 93(1):20-7. PubMed ID: 11842535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients.
    Tewari A; Shinohara K; Narayan P
    Urology; 1995 Feb; 45(2):258-64; discussion 265. PubMed ID: 7531900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.
    Roehrborn CG; McConnell JD; Lieber M; Kaplan S; Geller J; Malek GH; Castellanos R; Coffield S; Saltzman B; Resnick M; Cook TJ; Waldstreicher J
    Urology; 1999 Mar; 53(3):473-80. PubMed ID: 10096369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with lower urinary tract symptoms.
    Witjes WP; Aarnink RG; Ezz-el-Din K; Wijkstra H; Debruyne EM; de la Rosette JJ
    Br J Urol; 1997 Jul; 80(1):84-90. PubMed ID: 9240186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition zone ratio and prostate-specific antigen density: the index of response of benign prostatic hypertrophy to an alpha blocker.
    Kurita Y; Ushiyama T; Suzuki K; Fujita K; Kawabe K
    Int J Urol; 1996 Sep; 3(5):361-6. PubMed ID: 8886912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.